chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Gout, Peripheral swelling, Vaccination site induration, Vaccination site pain
Clinical narrative: Foot swelled up a balloon; gout flare up; Injected arm  felt tight; Injected arm  felt sore; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Foot swelled up a balloon), GOUT (gout flare up), VACCINATION SITE INDURATION (Injected arm  felt tight) and VACCINATION SITE PAIN (Injected arm  felt sore) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     Concurrent medical conditions included Gout. Concomitant products included FENOFIBRATE, ALLOPURINOL and COLCHICINE for an unknown indication.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-May-2021, the patient experienced VACCINATION SITE INDURATION (Injected arm  felt tight) and VACCINATION SITE PAIN (Injected arm  felt sore). On 17-May-2021, the patient experienced PERIPHERAL SWELLING (Foot swelled up a balloon) and GOUT (gout flare up). The patient was treated with PARACETAMOL (TYLENOL) on 15-May-2021 for Vaccination site pain, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Foot swelled up a balloon) was resolving and GOUT (gout flare up), VACCINATION SITE INDURATION (Injected arm  felt tight) and VACCINATION SITE PAIN (Injected arm  felt sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that swelling of foot going down on 18-May-2021  Treatment: Soaking in Epsom's salt bath and steroid patch.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: experiencing nausea /   I felt kind of nauseous, and it was still there this morning; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (experiencing nausea /   I felt kind of nauseous, and it was still there this morning) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B2A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced NAUSEA (experiencing nausea /   I felt kind of nauseous, and it was still there this morning). At the time of the report, NAUSEA (experiencing nausea /   I felt kind of nauseous, and it was still there this morning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitants were reported.  No treatment was reported. Reporter stated that Patient should receive the second dose on 08apr2021 and had a scheduled back surgery in 12apr2021.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: received first dose on 8Feb2021, unsure if she got the second dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received first dose on 8Feb2021, unsure if she got the second dose.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (received first dose on 8Feb2021, unsure if she got the second dose.). On 08-Feb-2021, PRODUCT DOSE OMISSION ISSUE (received first dose on 8Feb2021, unsure if she got the second dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment drugs were reported   Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Electrocardiogram, Product dose omission issue
Clinical narrative: got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose; pain in the chest; difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain in the chest), DYSPNOEA (difficulty breathing) and PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced CHEST PAIN (pain in the chest) and DYSPNOEA (difficulty breathing). On 18-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose). On 01-Apr-2021, CHEST PAIN (pain in the chest) and DYSPNOEA (difficulty breathing) had resolved. On 18-May-2021, PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (Inconclusive) inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided. Patient does not take any medication regularly. No concomitant medication information was provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose is scheduled on 23-Apr-2021 which is at 42 days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is scheduled on 23-Apr-2021 which is at 42 days after the first dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical history information was provided.  Concomitant products included ATORVASTATIN, ISOSORBIDE MONONITRATE, CYANOCOBALAMIN (B12-VITAMIIN) and FOLIC ACID for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is scheduled on 23-Apr-2021 which is at 42 days after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is scheduled on 23-Apr-2021 which is at 42 days after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is scheduled to receive the second dose is scheduled on 23-Apr-2021 which is at 42 days after the first dose.  Patient is undergoing chemotherapy and usually does not feel well after. No treatment medications were reported
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Insomnia, Paraesthesia, Pruritus, Rash
Clinical narrative: itchy; red; There is like a sensation of being sting; not sleeping; now is worst; severe rash on all the body/ started with a rash in the thorax, abdomen, breast, and then on the arms; really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps), PRURITUS (itchy), ERYTHEMA (red), PARAESTHESIA (There is like a sensation of being sting) and INSOMNIA (not sleeping) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced SWELLING (really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps) and RASH (severe rash on all the body/ started with a rash in the thorax, abdomen, breast, and then on the arms). On an unknown date, the patient experienced PRURITUS (itchy), ERYTHEMA (red), PARAESTHESIA (There is like a sensation of being sting), INSOMNIA (not sleeping) and VACCINATION COMPLICATION (now is worst). The patient was treated with PREDNISONE on 16-May-2021 at a dose of 1 dosage form. At the time of the report, SWELLING (really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps), PRURITUS (itchy), ERYTHEMA (red), PARAESTHESIA (There is like a sensation of being sting), INSOMNIA (not sleeping), VACCINATION COMPLICATION (now is worst) and RASH (severe rash on all the body/ started with a rash in the thorax, abdomen, breast, and then on the arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow-up information received on 11-Jul-2021 narrative translation updated.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination complication
Clinical narrative: itchy; red; There is like a sensation of being sting; not sleeping; now is worst; severe rash on all the body/ started with a rash in the thorax, abdomen, breast, and then on the arms; really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps), PRURITUS (itchy), ERYTHEMA (red), PARAESTHESIA (There is like a sensation of being sting) and INSOMNIA (not sleeping) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced SWELLING (really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps) and RASH (severe rash on all the body/ started with a rash in the thorax, abdomen, breast, and then on the arms). On an unknown date, the patient experienced PRURITUS (itchy), ERYTHEMA (red), PARAESTHESIA (There is like a sensation of being sting), INSOMNIA (not sleeping) and VACCINATION COMPLICATION (now is worst). The patient was treated with PREDNISONE on 16-May-2021 at a dose of 1 dosage form. At the time of the report, SWELLING (really big bumps/smaller bumps on the neck/the bumps are not on the face but they are on the ears/swollen with huge bumps), PRURITUS (itchy), ERYTHEMA (red), PARAESTHESIA (There is like a sensation of being sting), INSOMNIA (not sleeping), VACCINATION COMPLICATION (now is worst) and RASH (severe rash on all the body/ started with a rash in the thorax, abdomen, breast, and then on the arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow-up information received on 11-Jul-2021 narrative translation updated.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Musculoskeletal stiffness, Neurological symptom, Tremor
Clinical narrative: Stiffness; Neurological reaction; Tremors,shook so bad had to go to bed; Scared to death; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness), NEUROLOGICAL SYMPTOM (Neurological reaction), TREMOR (Tremors,shook so bad had to go to bed), FEELING ABNORMAL (Scared to death) and HEADACHE (Severe headache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness), NEUROLOGICAL SYMPTOM (Neurological reaction), TREMOR (Tremors,shook so bad had to go to bed), FEELING ABNORMAL (Scared to death) and HEADACHE (Severe headache). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness), NEUROLOGICAL SYMPTOM (Neurological reaction), TREMOR (Tremors,shook so bad had to go to bed), FEELING ABNORMAL (Scared to death) and HEADACHE (Severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided.   This case was linked to MOD-2021-141603 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: hardness at spot just below vaccination location; redness at spot just below vaccination location; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE INDURATION (hardness at spot just below vaccination location) and VACCINATION SITE ERYTHEMA (redness at spot just below vaccination location) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced VACCINATION SITE INDURATION (hardness at spot just below vaccination location) and VACCINATION SITE ERYTHEMA (redness at spot just below vaccination location). At the time of the report, VACCINATION SITE INDURATION (hardness at spot just below vaccination location) and VACCINATION SITE ERYTHEMA (redness at spot just below vaccination location) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medicines were not provided,  Action taken with mRNA-1273 in response to the event was Unknown
Sex: F
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: Breastfeeding post vaccination; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding post vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (Breastfeeding post vaccination). At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding post vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported.  Treatment medication was not reported.  The patient wanted to know if breastmilk samples are being collected. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 11-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding post vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (Breastfeeding post vaccination). At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding post vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported.  Treatment medication was not reported.  The patient wanted to know if breastmilk samples are being collected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Discoloured vomit
Clinical narrative: Dry cough; Threw up black stuff; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), DISCOLOURED VOMIT (Threw up black stuff) and DIARRHOEA (Diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0291A21A) for COVID-19 vaccination.     The patient's past medical history included Liver disorder.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced COUGH (Dry cough), DISCOLOURED VOMIT (Threw up black stuff) and DIARRHOEA (Diarrhea). At the time of the report, COUGH (Dry cough), DISCOLOURED VOMIT (Threw up black stuff) and DIARRHOEA (Diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment included cough medicine. Action taken with mRNA-1273 in response to the event was unknown   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow-up information received on 19-Jun-2021 contains non-significant information.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site bruising, Vaccination site mass
Clinical narrative: Fever; lamp with bruise; lamp with bruise; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (lamp with bruise), VACCINATION SITE MASS (lamp with bruise) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003621A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 16-May-2021, the patient experienced VACCINATION SITE BRUISING (lamp with bruise) and VACCINATION SITE MASS (lamp with bruise). On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, VACCINATION SITE BRUISING (lamp with bruise), VACCINATION SITE MASS (lamp with bruise) and PYREXIA (Fever) had resolved.            Patient applied ice on lump for 2 weeks.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jul-2021: Significant FU received on 17-JUL-2021. contains AE outcome updated
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-May-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved.            Concomitant medications included a medication that causes constipation, stool softener, and fiber medicine.  Treatment information was not provided by the reporter.  Action taken with the drug in response to the event was not applicable.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Movement disorder, Myalgia, Pain
Clinical narrative: the pain is just bothering me; Pain in my arm from first dose; my left arm is hard to move; I can not lift my clothes or pull my pants; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (my left arm is hard to move), MOVEMENT DISORDER (I can not lift my clothes or pull my pants), PAIN (the pain is just bothering me) and MYALGIA (Pain in my arm from first dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced HYPOKINESIA (my left arm is hard to move), MOVEMENT DISORDER (I can not lift my clothes or pull my pants) and MYALGIA (Pain in my arm from first dose). On an unknown date, the patient experienced PAIN (the pain is just bothering me). At the time of the report, HYPOKINESIA (my left arm is hard to move), MOVEMENT DISORDER (I can not lift my clothes or pull my pants), PAIN (the pain is just bothering me) and MYALGIA (Pain in my arm from first dose) had not resolved.            No Concomitant medications were reported. No treatment medications were reported. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Case Received From deleted, Correspondence Contact selected, Medically Confirm removed.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 years, 10 Months old patient received the Moderna Covid -19 Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years, 10 Months old patient received the Moderna Covid -19 Vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years, 10 Months old patient received the Moderna Covid -19 Vaccine). On 15-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years, 10 Months old patient received the Moderna Covid -19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasopharyngitis, Pruritus, Vaccination site erythema
Clinical narrative: itchy; I feel like I have a slight cold; stuffed up; big red blot on injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), NASOPHARYNGITIS (I feel like I have a slight cold), NASAL CONGESTION (stuffed up) and VACCINATION SITE ERYTHEMA (big red blot on injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PRURITUS (itchy), NASOPHARYNGITIS (I feel like I have a slight cold), NASAL CONGESTION (stuffed up) and VACCINATION SITE ERYTHEMA (big red blot on injection site). At the time of the report, PRURITUS (itchy), NASOPHARYNGITIS (I feel like I have a slight cold), NASAL CONGESTION (stuffed up) and VACCINATION SITE ERYTHEMA (big red blot on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and Concomitant medicines were not provided
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Myalgia
Clinical narrative: developed abdominal pain; shoulder pain; muscle pain; This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL PAIN (developed abdominal pain), ARTHRALGIA (shoulder pain) and MYALGIA (muscle pain) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No medical reported history provided by the reporter.  Concomitant products included LITHIUM and DIPHENHYDRAMINE for an unknown indication.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced ABDOMINAL PAIN (developed abdominal pain), ARTHRALGIA (shoulder pain) and MYALGIA (muscle pain). At the time of the report, ABDOMINAL PAIN (developed abdominal pain), ARTHRALGIA (shoulder pain) and MYALGIA (muscle pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Persistent but sporadic cough), DYSPNOEA (Unable to hold the air), DIZZINESS (Dizzy), MYALGIA (Pain in the arm /muscle aches) and FATIGUE (Tired/ fatigued) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced MYALGIA (Pain in the arm /muscle aches). On 13-May-2021, the patient experienced DIZZINESS (Dizzy). On 14-May-2021, the patient experienced FATIGUE (Tired/ fatigued). In May 2021, the patient experienced COUGH (Persistent but sporadic cough), DYSPNOEA (Unable to hold the air) and HEADACHE (Headaches). On 14-May-2021, MYALGIA (Pain in the arm /muscle aches) had resolved. On 15-May-2021, DIZZINESS (Dizzy) had resolved, HEADACHE (Headaches) had resolved. On 16-May-2021, FATIGUE (Tired/ fatigued) had resolved. At the time of the report, COUGH (Persistent but sporadic cough) and DYSPNOEA (Unable to hold the air) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.  Reporter did not allow further contact.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Persistent but sporadic cough), DYSPNOEA (Unable to hold the air), DIZZINESS (Dizzy), MYALGIA (Pain in the arm /muscle aches) and FATIGUE (Tired/ fatigued) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced MYALGIA (Pain in the arm /muscle aches). On 13-May-2021, the patient experienced DIZZINESS (Dizzy). On 14-May-2021, the patient experienced FATIGUE (Tired/ fatigued). In May 2021, the patient experienced COUGH (Persistent but sporadic cough), DYSPNOEA (Unable to hold the air) and HEADACHE (Headaches). On 14-May-2021, MYALGIA (Pain in the arm /muscle aches) had resolved. On 15-May-2021, DIZZINESS (Dizzy) had resolved, HEADACHE (Headaches) had resolved. On 16-May-2021, FATIGUE (Tired/ fatigued) had resolved. At the time of the report, COUGH (Persistent but sporadic cough) and DYSPNOEA (Unable to hold the air) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.  Reporter did not allow further contact.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Red swollen lump on injection site .; Itchy lump; Red swollen lump on injection site .; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (Red swollen lump on injection site .), VACCINATION SITE PRURITUS (Itchy lump) and VACCINATION SITE ERYTHEMA (Red swollen lump on injection site .) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, the patient experienced VACCINATION SITE MASS (Red swollen lump on injection site .), VACCINATION SITE PRURITUS (Itchy lump) and VACCINATION SITE ERYTHEMA (Red swollen lump on injection site .). At the time of the report, VACCINATION SITE MASS (Red swollen lump on injection site .), VACCINATION SITE PRURITUS (Itchy lump) and VACCINATION SITE ERYTHEMA (Red swollen lump on injection site .) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Med Info Agent: Patient called and reported the Adverse event , experienced after the first dose of Moderna vaccine on 8May 2021. After one week of getting the shot on 16 May 2021, patient developed  red swollen lump on injection site which continued  to grow and got bigger. Lump is itchy. Injection was given on the left upper arm , intramuscular .Caller did not provide the expiration for the vaccine .Consent for safety follow up was given via email
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Administered vaccine to a 16 year old/ Vaccine administered to a patient who is under 16 years old based on the date of birth provided/ Pharmacist confirmed the date of birth and agreed that patient did not turn 16 yet; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered vaccine to a 16 year old/ Vaccine administered to a patient who is under 16 years old based on the date of birth provided/ Pharmacist confirmed the date of birth and agreed that patient did not turn 16 yet) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered vaccine to a 16 year old/ Vaccine administered to a patient who is under 16 years old based on the date of birth provided/ Pharmacist confirmed the date of birth and agreed that patient did not turn 16 yet). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered vaccine to a 16 year old/ Vaccine administered to a patient who is under 16 years old based on the date of birth provided/ Pharmacist confirmed the date of birth and agreed that patient did not turn 16 yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Warm Transferred case number 00166244  A pharmacist called in on 18May2021 to report that the first dose of Moderna COVID-19 vaccine was administered to a 16 year old on 17May2021 (Lot number: 033C21A, Expiration date: 27Oct2021) in the left arm. Caller denies knowledge of any adverse reactions experienced by the patient or any treatments used.  On 18May2021 at 1:05 PM EST the agent reached out to the healthcare provider to verify the patient's age. Pharmacist confirmed the date of birth and agreed that patient did not turn 16 yet.  Consent to contact the pharmacist granted. Preferred method: telephone or email.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Email received
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient was tested positive for covid about 25 days after receiving 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient was tested positive for covid about 25 days after receiving 1st dose) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 05-May-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Patient was tested positive for covid about 25 days after receiving 1st dose). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient was tested positive for covid about 25 days after receiving 1st dose) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, COVID-19: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   05/May/2021,the patient was tested positive for COVID. The finished quarantine period of 14 days. Concomitant medication and treatment details were not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain in extremity, Somnolence
Clinical narrative: Sleepy; Sore arm; Feels achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), PAIN IN EXTREMITY (Sore arm), PAIN (Feels achy) and FATIGUE (Tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 044B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced SOMNOLENCE (Sleepy), PAIN IN EXTREMITY (Sore arm), PAIN (Feels achy) and FATIGUE (Tired). At the time of the report, SOMNOLENCE (Sleepy), PAIN IN EXTREMITY (Sore arm), PAIN (Feels achy) and FATIGUE (Tired) outcome was unknown.         Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hypersensitivity
Clinical narrative: Severe allergic reaction; Dizziness; This spontaneous case was reported by a pharmacist and describes the occurrence of DIZZINESS (Dizziness) and HYPERSENSITIVITY (Severe allergic reaction) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042821A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced DIZZINESS (Dizziness). On an unknown date, the patient experienced HYPERSENSITIVITY (Severe allergic reaction). The patient was treated with DIMENHYDRINATE (DRAMAMINE) at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness) and HYPERSENSITIVITY (Severe allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was provided as c band acupuncture device.  It was reported that the pharmacist suggested the patient not to get the second dose as the patient had allergic reactions.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise
Clinical narrative: doesn't feel that great; What she is feeling right now is similar to how she felt with covid.; This spontaneous case was reported by a health care professional and describes the occurrence of MALAISE (doesn't feel that great) and FEELING ABNORMAL (What she is feeling right now is similar to how she felt with covid.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (doesn't feel that great) and FEELING ABNORMAL (What she is feeling right now is similar to how she felt with covid.). At the time of the report, MALAISE (doesn't feel that great) and FEELING ABNORMAL (What she is feeling right now is similar to how she felt with covid.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable No concomitant medications were reported No treatment drugs were reported
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Caller's husband received first dose of Moderna vaccine on 20Feb2021 and second dose 20Mar2021, but it was the Pfizer vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Caller's husband received first dose of Moderna vaccine on 20Feb2021 and second dose 20Mar2021, but it was the Pfizer vaccine.) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and EP7534) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, NAPROXEN, PRAVASTATIN, FLUOXETINE and MECLIZINE [MECLOZINE] for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Caller's husband received first dose of Moderna vaccine on 20Feb2021 and second dose 20Mar2021, but it was the Pfizer vaccine.). On 20-Mar-2021, INTERCHANGE OF VACCINE PRODUCTS (Caller's husband received first dose of Moderna vaccine on 20Feb2021 and second dose 20Mar2021, but it was the Pfizer vaccine.) had resolved.            Co-suspect vaccine given was Pfizer vaccine on 20-Mar-2021.  No treatment medication was provided   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received on 24-MAY-2021 included no new information On 18-Jul-2021: Additional information included patient height and weight and dose information.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Feeling cold, Headache, Inflammation
Clinical narrative: All my chest is swollen and my arm; The inflammation in my axilla is still present; All my chest is swollen and my arm; Chills; My right axilla is swollen; Fever; Body pain; Headache; Very intense right arm  pain; Body is cold; Bone pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Body is cold), BONE PAIN (Bone pain), PERIPHERAL SWELLING (All my chest is swollen and my arm), INFLAMMATION (The inflammation in my axilla is still present) and SWELLING (All my chest is swollen and my arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL and CREATINE, INULIN, LEVOGLUTAMIDE, LYSINE, PROTEINS NOS, SPIRULINA SPP., TAURINE, VITAMINS NOS (VEGAN PROTEIN) for an unknown indication.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced FEELING COLD (Body is cold), BONE PAIN (Bone pain) and PAIN IN EXTREMITY (Very intense right arm  pain   ). On 16-May-2021, the patient experienced SWELLING (All my chest is swollen and my arm), CHILLS (Chills), LYMPHADENOPATHY (My right axilla is swollen), PYREXIA (Fever), MYALGIA (Body pain) and HEADACHE (Headache). On 17-May-2021, the patient experienced INFLAMMATION (The inflammation in my axilla is still present). On an unknown date, the patient experienced PERIPHERAL SWELLING (All my chest is swollen and my arm). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) (oral) at a dose of 500 gram twice a day and IBUPROFEN (oral) at a dose of 800 gram twice a day. At the time of the report, FEELING COLD (Body is cold), BONE PAIN (Bone pain), PERIPHERAL SWELLING (All my chest is swollen and my arm), SWELLING (All my chest is swollen and my arm), PAIN IN EXTREMITY (Very intense right arm  pain   ), CHILLS (Chills), LYMPHADENOPATHY (My right axilla is swollen), PYREXIA (Fever), MYALGIA (Body pain) and HEADACHE (Headache) outcome was unknown and INFLAMMATION (The inflammation in my axilla is still present) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: All my chest is swollen and my arm; The inflammation in my axilla is still present; All my chest is swollen and my arm; Chills; My right axilla is swollen; Fever; Body pain; Headache; Very intense right arm  pain; Body is cold; Bone pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Body is cold), BONE PAIN (Bone pain), PERIPHERAL SWELLING (All my chest is swollen and my arm), INFLAMMATION (The inflammation in my axilla is still present) and SWELLING (All my chest is swollen and my arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL and CREATINE, INULIN, LEVOGLUTAMIDE, LYSINE, PROTEINS NOS, SPIRULINA SPP., TAURINE, VITAMINS NOS (VEGAN PROTEIN) for an unknown indication.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced FEELING COLD (Body is cold), BONE PAIN (Bone pain) and PAIN IN EXTREMITY (Very intense right arm  pain   ). On 16-May-2021, the patient experienced SWELLING (All my chest is swollen and my arm), CHILLS (Chills), LYMPHADENOPATHY (My right axilla is swollen), PYREXIA (Fever), MYALGIA (Body pain) and HEADACHE (Headache). On 17-May-2021, the patient experienced INFLAMMATION (The inflammation in my axilla is still present). On an unknown date, the patient experienced PERIPHERAL SWELLING (All my chest is swollen and my arm). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) (oral) at a dose of 500 gram twice a day and IBUPROFEN (oral) at a dose of 800 gram twice a day. At the time of the report, FEELING COLD (Body is cold), BONE PAIN (Bone pain), PERIPHERAL SWELLING (All my chest is swollen and my arm), SWELLING (All my chest is swollen and my arm), PAIN IN EXTREMITY (Very intense right arm  pain   ), CHILLS (Chills), LYMPHADENOPATHY (My right axilla is swollen), PYREXIA (Fever), MYALGIA (Body pain) and HEADACHE (Headache) outcome was unknown and INFLAMMATION (The inflammation in my axilla is still present) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.